TP53 and cancer: Of note, while the aberrations of APC and TP53 frequently co‐occurred with NTRK fusions, these fusions rarely coexisted with other activating driver mutations, consistent with what was previously reported for the NTRK rearrangement in a pan‐cancer setting by Rosen et al.19